FDA Finalizes Guidance on Benign Prostatic Hyperplasia Device Studies
February 1, 2022
The FDA has issued final guidance to offer its advice on designing clinical trials for benign prostatic hyperplasia (BPH) devices, citing the condition’s prevalence in older male populations.